BCS class IV drugs: Highly notorious candidates for formulation development
Year: 2017
Type: review
Source: Journal of Controlled Release
Authors: Rohan Ghadi, Neha Dand
Language: English
Subfield: Pharmaceutical Science
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2578110183
